about
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infectionGut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?Therapeutic modulation of gut microbiota: current clinical applications and future perspectives.Role of microbiota and innate immunity in recurrent Clostridium difficile infection.Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitementThe involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease.Prior Misdiagnosis of Celiac Disease Is Common Among Patients Referred to a Tertiary Care Center: A Prospective Cohort Study.Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report SeriesSystematic review: Sprue-like enteropathy associated with olmesartan.Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.Is there a role for gut microbiota in type 1 diabetes pathogenesis?Chronic autoimmune disorders are increased in coeliac disease: A case–control study.Fecal microbiota transplantation: past, present and future perspectives.Cancer time trend in a population following a socio-economic transition: results of age-period-cohort analysis.Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference.Increased Frequency of Immune Thrombocytopenic Purpura in Coeliac Disease and Vice Versa: A Prospective Observational Study.Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease.Response to: Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease"Role of Probiotics in Eradication: Lessons from a Study of Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump InhibitorLetter: telmisartan associated enteropathy - is there any class effect? Authors' replyConstipation in the elderly from Northern Sardinia is positively associated with depression, malnutrition and female genderFecal transplantation for ulcerative colitis: current evidence and future applicationsCoeliac disease: beyond genetic susceptibility and gluten. A narrative reviewReactive arthritis secondary to Hafnia alvei enterocolitisFecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
P50
Q28258066-AB38B630-4FD2-4936-B52D-54F96819A1C5Q35130335-2F33C9EB-A740-45B4-9130-E8D84C92C2CFQ35183703-B6C3E379-FD68-45A4-A3D6-89228392E6E9Q35201232-7E8A661A-6E41-4D16-9BA9-AF4A07BD93FFQ35361200-C2CE0E04-759D-42C9-A738-0A68265E8FF4Q35538584-D393BA6E-5BB4-40D4-A95C-2FC8ABA0C34EQ35633769-2089380E-2142-47D2-9FCF-F1AA73F78791Q36534718-2283FDBC-F2EF-4E59-BC79-B882C31E6D31Q36822577-CDB11E1D-1D5A-43BC-AD31-DA3952803E4AQ38209994-3CABCD32-BB24-4544-8E6D-6BAA69A82133Q38212210-730BA103-0FD4-43A7-B487-CDE32661E7B6Q38970657-26EFB81A-63A0-4513-9234-CAC4E6024453Q40383606-2803C24E-8F60-4EB6-9C63-FEC86885C76EQ40631825-2FCB5F28-38DA-4319-9A04-BB29CAFAD693Q47148348-0C961EDD-B8F8-4BE9-B322-F2B7EA94DF42Q47940758-7BFC1FFA-43D5-4846-858E-8103EF2D1B32Q48199912-B22F8B74-88A6-468D-B9A3-70CA8941561BQ52887574-6D4AF8DF-B480-4A4A-91E6-4D6CFF040219Q53063803-03A3FD45-C7FE-4D24-A3B2-BC8B61E68E63Q54998590-C0B299F3-ADD3-43BB-A606-EB2BB3D685ADQ55008998-82093D1C-9562-4E89-982D-A2E80B4400DCQ58766211-6FA00D64-2FE3-4842-BCF0-9BE4E0648372Q64090104-64C6B08D-AC0C-4F05-AB0E-4B389AB01C8AQ87522638-9D993BEE-599E-4A0C-B3BC-F855C4B5AB93Q88739690-B8EC8C9D-3FA7-4ECA-83FD-0B6582C0E5AEQ89826969-2F701110-6F25-4562-8BB0-96C48EA3E813Q91439326-CE00D07F-6F07-4B54-94E0-6B60CD2B936EQ92380140-55C912D6-AD58-4EFE-9011-0CE51AA78C4BQ96225737-19D49B39-D12A-43C2-856A-ABFE5D80EDAF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefano Bibbò
@ast
Stefano Bibbò
@en
Stefano Bibbò
@es
Stefano Bibbò
@sl
type
label
Stefano Bibbò
@ast
Stefano Bibbò
@en
Stefano Bibbò
@es
Stefano Bibbò
@sl
prefLabel
Stefano Bibbò
@ast
Stefano Bibbò
@en
Stefano Bibbò
@es
Stefano Bibbò
@sl
P106
P1153
56072992400
P21
P31
P496
0000-0002-8043-4807